Downloads
-
A Stable Cell Line For Inducible AAV Production
3/6/2024
Delivering on the promise of AAV-based gene therapies beyond rare diseases will require large quantities of high-quality AAV, produced in a robust manner.
-
Five Essentials For Accurate Oligonucleotide Chemistry
3/4/2024
Explore five key areas in oligonucleotide chemistry where improvements will have a huge influence on your synthesis quality.
-
The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.
3/3/2024
In biotech, when "one of these things doesn't look like the other one," it can be a blessing or a curse. On one hand, scientific novelty is praised and rewarded. On the other, unfamiliarity breeds skepticism from the investment community. Brian Finrow, J.D. embraces that reality and the challenges that come with it.
-
Custom Organ-Chips For 3D Gel Matrices And Direct Compound Dosing
3/1/2024
Learn how you can study human physiology and test compounds with custom Organ-Chip models that suit applications necessitating 3D gel matrices or direct compound dosing.
-
Emulate Contract Research Services
3/1/2024
Understand and predict human response for your drug candidates with expert help. Explore contract research services for researchers seeking to harness the advantages of organ-on-a-chip technology.
-
Custom Organ-Chip Models For Various Applications
3/1/2024
Discover how you can harness the power of a living, micro-engineered environment that mimics the complex physiological conditions and mechanical forces cells experience within the human body.
-
Redefining Drug Discovery And Development
3/1/2024
Learn about a solution for next-generation in vitro models that leverages cutting-edge organ-on-a-chip technology to emulate human biology with unparalleled accuracy compared to conventional models
-
The Future of Rare Diseases with The Jackson Laboratory’s Rare Disease Translational Center's Cat Lutz
2/29/2024
Rare Disease Day is February 29, 2024, and in honor of this important day, Cell & Gene: The Podcast Host Erin Harris sits down with Jackson Laboratory’s (JAX) Rare Disease Translational Center (RDTC)'s VP, Cat Lutz.
-
FDA’s Updated Guidance On Human Genome Editing: New Implications & Remaining Questions
2/27/2024
On Jan. 29, 2024, the FDA released the final version of the guidance document on human gene therapy products incorporating genome editing. This article shares what changed between the draft and now final version of the guidance, and what open questions remain for the industry and scientific community to help resolve.
-
AI's Role In Advancing Rare Disease Research
2/27/2024
IndoUSrare experts explore the global issues in rare disease research and examine how AI is poised to revolutionize the diagnosis and treatment of these often-overlooked conditions.